Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States
Transfusion · 2024
DOI: 10.1111/trf.18011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Jeremy W Jacobs und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Erythroblastosis, Fetal, Transfusion Medicine, Blood Banks. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Hemolytic disease of the fetus and newborn (HDFN) is caused by maternal alloantibody‐mediated destruction of fetal/neonatal red blood cells (RBCs). While the pathophysiology has been well‐characterized, the clinical and laboratory monitoring practices are inconsistent.
Methods
We surveyed 103 US institutions to characterize laboratory testing practices for individuals with fetuses at risk of HDFN. Questions included antibody testing and titration methodologies, the use of critical titers, paternal and cell‐free fetal DNA testing, and result reporting and documentation practices.
Results
The response rate was 44% (45/103). Most respondents (96%, 43/45) assess maternal antibody titers, primarily using conventional tube‐based methods only (79%, 34/43). Among respondents, 51% (23/45) rescreen all individuals for antibodies in the third trimester, and 60% (27/45) perform paternal RBC antigen testing. A minority (27%, 12/45) utilize cell‐free fetal DNA (cffDNA) testing to predict fetal antigen status. Maternal antibody titers are performed even when the fetus is not considered to be at risk of HDFN based on cffDNA or paternal RBC antigen testing at 23% (10/43) of sites that assess titers.
Discussion
There is heterogeneity across US institutions regarding the testing, monitoring, and reporting practices for pregnant individuals with fetuses at risk of HDFN, including the use of antibody titers in screening and monitoring programs, the use of paternal RBC antigen testing and cffDNA, and documentation of fetal antigen results. Standardization of laboratory testing protocols and closer collaboration between the blood bank and transfusion medicine service and the obstetric/maternal‐fetal medicine service are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Pathology, Microbiology, & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Women's Health, Dell Medical School, University of Texas at Austin, Austin, Texas, USA.
- Comprehensive Fetal Care Center, Dell Children's Medical Center, Austin, Texas, USA.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Jeremy W Jacobs, Garrett S Booth, Kenneth J Moise, Brian D Adkins, Sara Bakhtary, Ross M Fasano, Ruchika Goel, Laura D Stephens, Christopher A Tormey, Elizabeth P Crowe, Evan M Bloch, Elizabeth A Abels
Zitieren
APA
Jacobs, J. W., Booth, G. S., Moise, K. J., Adkins, B. D., Bakhtary, S., Fasano, R. M., Goel, R., Hinton, H. D., Laghari, S. A., Stephens, L. D., Tormey, C. A., Crowe, E. P., Bloch, E. M., & Abels, E. A. (2024). Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States. Transfusion. https://doi.org/10.1111/trf.18011
Vancouver
Jacobs JW, Booth GS, Moise KJ, Adkins BD, Bakhtary S, Fasano RM, et al. Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States. Transfusion. 2024. doi:10.1111/trf.18011
BibTeX
@article{Jacobs2024,
author = {Jacobs, Jeremy W and Booth, Garrett S and Moise, Kenneth J and Adkins, Brian D and Bakhtary, Sara and Fasano, Ross M and Goel, Ruchika and Hinton, Hannah D and Laghari, Sadia A and Stephens, Laura D and Tormey, Christopher A and Crowe, Elizabeth P and Bloch, Evan M and Abels, Elizabeth A},
title = {Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.18011}
}
EUVIMED